Genome & Company (KOSDAQ:314130)

Genome & Company Revenue

Genome & Company had revenue of 5.81B KRW in the quarter ending June 30, 2025, a decrease of -50.04%. This brings the company's revenue in the last twelve months to 24.02B, up 0.39% year-over-year. In the year 2024, Genome & Company had annual revenue of 27.74B with 94.07% growth.

• Revenue (ttm): 24.02B
• Revenue Growth: +0.39%
• P/S Ratio: 3.68
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 88.44B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	27.74B	13.45B	94.07%
Dec 31, 2023	14.30B	211.39M	1.50%
Dec 31, 2022	14.08B	13.63B	3,021.27%
Dec 31, 2021	451.25M	300.66M	199.67%
Dec 31, 2020	150.58M	104.75M	228.54%